|
| | Ufiprazole Chemical Properties |
| Melting point | 122.0 to 126.0 °C | | Boiling point | 539.7±60.0 °C(Predicted) | | density | 1.28±0.1 g/cm3(Predicted) | | storage temp. | Keep in dark place,Sealed in dry,Room Temperature | | solubility | DMSO (Slightly), Methanol (Slightly) | | form | Solid | | pka | 9.81±0.10(Predicted) | | color | White to Off-White | | λmax | 307nm(MeOH)(lit.) | | InChI | InChI=1S/C17H19N3O2S/c1-10-8-18-15(11(2)16(10)22-4)9-23-17-19-13-6-5-12(21-3)7-14(13)20-17/h5-8H,9H2,1-4H3,(H,19,20) | | InChIKey | XURCIPRUUASYLR-UHFFFAOYSA-N | | SMILES | C1(SCC2=NC=C(C)C(OC)=C2C)NC2=CC(OC)=CC=C2N=1 | | CAS DataBase Reference | 73590-85-9(CAS DataBase Reference) |
| Hazard Codes | Xi | | Risk Statements | 36/37/38 | | Safety Statements | 26 | | WGK Germany | 3 | | HS Code | 29339900 |
| | Ufiprazole Usage And Synthesis |
| Synthesis | Ufiprazole can be synthesized by the condensation reaction of 2-mercapto-5-methoxybenzimidazole and 2-chloromethyl-4-methoxy-3,5-lutidine. | | Description | Omeprazole sulfide is an intermediate used in the production of the gastric proton pump inhibitors, omeprazole and esomeprazole . As a degradation product, it is reported to be a direct-acting inhibitor of cytochrome P450 2C19 in pooled human liver microsomes (IC50 = 9.7 μM). | | Uses | Omeprazole Sulfide (Esomeprazol EP Impurity C(Omeprazole EP Impurity C)) is a metabolite of Omeprazole. | | Definition | ChEBI: Omeprazole sulfide is a member of benzimidazoles. | | Biological Activity | Ufiprazole (Omeprazole sulfide) is an intermediate in the production of gastric proton pump inhibitors omeprazole and esomeprazole. |
| | Ufiprazole Preparation Products And Raw materials |
|